We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

U.S. Agency Seeks Reexamination Of Biotech Patent

Law360 (February 17, 2005, 12:00 AM EST) -- In a sign of the government’s increasing vigilance in protecting its patent rights, the U.S. Department of Health & Human Services has taken the highly unusual step of requesting an inter-partes reexamination of a patent for an anti-cancer antibody held by biotech company Immunomedics, Inc.

In its filing, the Department of HHS argues that the patent, filed in November 2001, was anticipated by another patent filed in September 1993 by the Department of HHS.

The patent, U.S. patent no. 6,653,104, is for “immunotoxins, comprising an internalizing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.